Last reviewed · How we verify
LY2140023 Reference form — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
LY2140023 Reference form (LY2140023 Reference form) — Denovo Biopharma LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LY2140023 Reference form TARGET | LY2140023 Reference form | Denovo Biopharma LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LY2140023 Reference form CI watch — RSS
- LY2140023 Reference form CI watch — Atom
- LY2140023 Reference form CI watch — JSON
- LY2140023 Reference form alone — RSS
Cite this brief
Drug Landscape (2026). LY2140023 Reference form — Competitive Intelligence Brief. https://druglandscape.com/ci/ly2140023-reference-form. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab